Briakinumab
Product Specifications
CAS Number
339308-60-0
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.9953
Bioactivity
Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the study of psoriasis, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
